New monoclonal antibodies or fusion proteins that specifically target B-cell survival or proliferation are, however, now becoming available. BCMA Stimulates plasma cell survival and IgM production ...
a transcription factor necessary for the transient expansion of B cells preceding plasma cell differentiation, via coupling its translation to its decay.
Last November, results from the MITIGATE trial made headlines at ACR Convergence 2024 with positive phase 3 trial data for inebilizumab, an IgG1 monoclonal antibody targeting CD19, in patients with ...
Research found that following a ketogenic diet for 6 months can reprogram immune cell metabolism and promote ...
DelveInsight's "CARVYKTI Market Size, Forecast, and Market Insight Report" highlights the details around CARVYKTI, a ...
People commonly refer to these as B cells and T cells. The job of T cells is to help the body kill cancer cells and control the immune response to foreign substances. They do this by destroying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results